BABetha Ariesanty

Betha Ariesanty

*This is an algorithmically generated author record based on publicly available information.

Betha Ariesanty has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Quantitative Antibody Levels in Hospital Workers after Receiving three Doses of CoviD-19 vaccines

    by Pompini Agustina Sitompul, Nina Mariana, Ervan Budiman, Dian Wahyu Tanjung, Betha Ariesanty, Teguh Sarry Hartono, Jahiroh Jahiroh, Christine Ernita, Aninda Dinar, Anita Puspitasari, et al.

    Hospital workers were at high risk for SARS-CoV-2 infection and the first population with authorized access to the three doses of vaccination against SARS-CoV-2 antigen. The study was aimed to compare SARS-CoV-2 antibody levels among hospital workers receiving the three doses of Covid-19 vaccines with a history of Covid-19 infection versus those without a history of infection. A cross sectional study was conducted at the Sulianti Saroso Infectious Disease Hospital (SSIDH) in December 2021. The inclusion criteria were hospital workers in both subjects with and without previous Covid-19 infection and those who had received 3 doses of Covid-19 vaccines. Anti SARS-CoV-2 antibody levels measured by the Architect of SARS-CoV-2 IgG II Quant. There were 75 participants in the study, the median of anti SARS CoV-2 levels reported 8724.4 AU/mL (3396.8, 15773.2 AU/mL, Interquartile range). They were divided into 2 groups according to the status of prior Covid-19 infection, hospital workers with and without previous of Covid-19 infection. There was no significance difference in antibody less than 25.000 AU/mL between hospital worker with and without previous Covid-19 infection (p=1,000). Meanwhile, the median of antibody levels was seen in the interval between the 3rd dose of vaccine within 1 month; 2 to 3 months; 4 to 5 months before the antibody measurement (14576.5 AU/mL;12407.4 AU/mL; 5778.1 AU/mL, respectively). In this study, after three doses of Covid-19 vaccines, there was no significance difference in antibody levels of hospital worker with and without previous Covid-19 infection.

  • Open Access

    The Use of Convalescent Plasma (CP) Transfusion Therapy in Moderate to Severe COVID-19 Patients: a Single Center Experience in Indonesia

    by Adiatmo Pratomo, Nina Mariana, Surya Otto Wijaya, Betha Ariesanty, Titi Sundari, Wahyu Tanjungsari, Herlina Herlina, Siti Maemun Siti Maemun, Farida Murtiani, Vivi Lisdawati, et al.

    Biomedical and Pharmacology Journal (BPJ) is an international, open access, peer reviewed, quarterly research journal.